Source comparisons
Approved comparison material connected to this topic. Only stored records are displayed.
Comparison
The following table compares validated dosing protocols across topical and systemic administration routes documented in peer-reviewed research. Topical (cream/serum) 0.05–1% by weight Once or twice daily Improved skin l…
Source: realpeptides.coComparison
Before selecting a GHK-Cu protocol, compare concentration, delivery system, and evidence basis across formulation types. This table summarizes the key variables that determine real-world efficacy. Aqueous serum (standar…
Source: realpeptides.coComparison
Subcutaneous injection delivers GHK-Cu directly into the interstitial space surrounding fibroblasts, bypassing the stratum corneum barrier that limits dermal penetration of topically applied peptides. Bioavailability fo…
Source: realpeptides.coComparison
Concentration listed on a product label and the bioavailable dose that reaches target tissue are not the same variable. A 2% GHK-Cu serum applied to intact stratum corneum delivers vastly less peptide-copper complex to …
Source: realpeptides.coComparison
Subcutaneous Injection 1–3 mg/kg bodyweight daily ~80% systemic absorption Twice daily (every 12 hours) Achieved within 30–60 minutes post-injection Preferred for systemic collagen remodeling. Highest bioavailability, m…
Source: realpeptides.coComparison
Superficial epidermal (first-degree) 0.5–1mg once daily Topical to wound bed 5–10 days 20–30% faster re-epithelialization Low bioavailability but sufficient for keratinocyte migration Partial-thickness dermal (second-de…
Source: realpeptides.coComparison
0.5–1mg Mild stimulation. Decorin upregulation without significant MMP activation Minimal First-time users, skin maintenance phase post-correction Once daily, morning Safe starting point but may underwhelm users seeking…
Source: realpeptides.coComparison
0.01–0.1% Maintenance serum, combination peptide formulas Daily prevention, barrier support, mild photoaging 8–12 weeks for barrier function improvement; limited collagen remodelling Sufficient for users under 35 with m…
Source: realpeptides.coComparison
Subcutaneous Injection 1–2mg in 0.5–1ml BAC water 3× weekly Full dermal + hypodermal delivery 18–23% increase in dermal thickness Highest efficacy but requires injection skill and sterile technique. Gold standard for me…
Source: realpeptides.coComparison
The best GHK-Cu dosage for skin rejuvenation depends entirely on the delivery method you're using. Subcutaneous injection, topical application, and microneedling require completely different concentration and frequency …
Source: realpeptides.coComparison
Before committing to a GHK-Cu protocol, compare it against other evidence-based scar treatments to understand where it fits in the hierarchy of clinical efficacy. GHK-Cu (systemic injection) Activates MMP-2/MMP-9 for co…
Source: realpeptides.coComparison
Standard Topical 2–3mg Once daily Liposomal serum Optional, monthly at 0.5mm 16–20 weeks Effective for mild thinning; requires consistent twice-daily application for sustained results Split-Dose Topical 1.5mg per applic…
Source: realpeptides.coComparison
Research-grade peptide (lab use) 5–10% in solution 0.8–1.6% elemental copper Once daily post-procedure Used in wound healing studies; not intended for intact skin cosmetic use Exceeds cosmetic safety thresholds. Irritat…
Source: realpeptides.coComparison
Subcutaneous Injection 1–3mg daily 85–92% 450–1200 Systemic anti-aging, wound healing, tissue remodeling Gold standard for measurable results. Direct bioavailability bypasses dermal penetration limits entirely Topical (…
Source: realpeptides.coComparison
Superficial epidermal (abrasions, minor burns) 200–300 µg/mL Twice daily days 0–5, once daily days 6–14 7–14 days Cost-effective for rapid re-epithelialization; minimal scar risk justifies lower concentration Partial-th…
Source: realpeptides.coComparison
The best GHK-Cu dosage antioxidant 2026 research uses subcutaneous injection at 1–1.5mg daily for systemic antioxidant upregulation, or oral administration at 2–3mg daily when injection isn't feasible. The route determi…
Source: realpeptides.coComparison
Subcutaneous Injection 1–3mg daily Once daily 85–90% 6–8 weeks for measurable collagen density increase Highest precision and bioavailability; requires sterile technique and proper storage; ideal for controlled research…
Source: realpeptides.coComparison
Subcutaneous injection protocols in published trials typically use 1–3mg GHK-Cu daily, administered in a single dose. A Phase II study evaluating GHK-Cu for photoaged skin used 2mg daily for 12 weeks and demonstrated st…
Source: realpeptides.coComparison
Systemic GHK-Cu administration (subcutaneous or intramuscular injection) achieves measurable plasma concentrations within 30–60 minutes, with a half-life of approximately 1.5–2 hours before hepatic metabolism. Research-…
Source: realpeptides.coComparison
Subcutaneous Injection 1–1.5mg daily ~90–95% 90–120 min Bypasses first-pass metabolism; lower dose achieves systemic effect Low if proper reconstitution technique used Oral (Fasted) 2–3mg daily ~40–50% 2–3 hours Non-inv…
Source: realpeptides.co